Sanofi (SNY) Non Operating Income (2009 - 2026)

Sanofi (SNY) posted Non Operating Income of -$430.8 million for Q4 2016, down 231.0% sequentially from -$130.2 million in Q1 2016, and down 3.16% YoY from -$444.9 million in Q1 2016.

Sanofi (SNY) Non Operating Income (2009 - 2026) Analysis & Trends

Sanofi (SNY) has 8 years of Non Operating Income data on file, last reported at -$430.8 million in Q4 2016.

  • Quarterly Non Operating Income fell 3.16% year-over-year to -$430.8 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was -$1.1 billion (down 42.67% YoY) and the FY2015 annual result came in at -$433.2 million, up 27.09% from the prior year.
  • Non Operating Income declined to -$430.8 million in Q4 2016 per SNY's latest filing, from -$130.2 million in the prior quarter.
  • The five-year high for Non Operating Income was -$104.1 million in Q1 2014, with the low at -$530.0 million in Q3 2013.
  • Average Non Operating Income over 5 years is -$224.3 million, with a median of -$181.7 million recorded in 2013.
  • Year-over-year, Non Operating Income slumped 213.93% in 2013 and soared 65.19% in 2014.
  • Sanofi's Non Operating Income stood at -$256.8 million in 2012, then sank by 46.82% to -$377.0 million in 2013, then surged by 54.25% to -$172.5 million in 2014, then sank by 142.13% to -$417.6 million in 2015, then fell by 3.16% to -$430.8 million in 2016.
  • Business Quant data shows SNY's Non Operating Income at -$430.8 million in Q4 2016, -$130.2 million in Q1 2016, and -$417.6 million in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -65.00 Mn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -294.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -2.31 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -3.49 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -138.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 75.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 235.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -861.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Sanofi - - 9.49 Bn 1.23 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.23 Bn
Dec 31, 2025 9.42 Bn
Mar 31, 2025 1.08 Bn
Dec 31, 2024 6.36 Bn
Mar 31, 2024 -471.48 Mn
Dec 31, 2023 7.97 Bn
Mar 31, 2023 1.65 Bn
Dec 31, 2022 8.65 Bn
Mar 31, 2022 1.92 Bn
Dec 31, 2021 9.26 Bn
Jun 30, 2021 1.72 Bn
Mar 31, 2021 2.32 Bn
Dec 31, 2020 8.32 Bn
Jun 30, 2020 2.21 Bn
Mar 31, 2020 1.72 Bn
Dec 31, 2019 6.66 Bn
Mar 31, 2019 932.04 Mn
Dec 31, 2018 4.63 Bn
Dec 31, 2017 8.01 Bn
Dec 31, 2016 8.06 Bn